Cellular Biomedicine Group Completes Enrollment in Phase I Clinical Trial for Knee Osteoarthritis

"We are pleased that our patient enrollment is on schedule with our projected time to complete the Phase I clinical trial for Knee Osteoarthritis," said Dr. Cheng The Phase I open label clinical research trial for KOA, registered with the U.S. National Institutes of Health under number NCT01809769 , tests the safety and efficacy of intra-articular ... (more)

http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Cellular-Biomedicine-Group-Completes-Enrollment-in/ArticleNewsFeed/Article/detail/818495?ref=25